\-\ Texto\\:\\ \ \(0\)\
\-\ normal\ \(4026\)\
\-\ surgical\\ removal\\ followed\\ by\\ radiation\\ therapy\\.\ \(0\)\
\-\ \\â\\€\\¢\\ ring\\ enhancing\\ lesion\\ left\\ frontal\\ lobe\\.\ \(0\)\
\-\ \\â\\€\\¢\\ minimal\\ edema\\ and\\ mass\\ effect\\.\ \(0\)\
\-\ \\â\\€\\¢\\ hyperintense\\ on\\ t2\\ and\\ hypointense\\ on\\ t1\\ sequences\ \(0\)\
\-\ glioblastoma\\ multiforme\ \(8\)\
\-\ \\â\\€\\¢\\ metastatic\\ disease\ \(13\)\
\-\ \\â\\€\\¢\\ primary\\ glioma\\ \\(high\\-grade\\ astrocytoma\\)\ \(1\)\
\-\ \\â\\€\\¢\\ abscess\ \(6\)\
\-\ \\â\\€\\¢\\ vasculitis\ \(1\)\
\-\ 56\\ year\\ old\\ man\\ had\\ trauma\\ screen\\ ct\\ following\\ an\\ atv\\ accident\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ atv\\:\\ 0\\.2850192230820604\ \(0\)\
\-\ multiforme\\:\\ 0\\.22239284264267944\ \(0\)\
\-\ screen\\:\\ 0\\.22012476971541078\ \(0\)\
\-\ glioblastoma\\:\\ 0\\.2128179283640762\ \(0\)\
\-\ 56\\:\\ 0\\.199293508086368\ \(0\)\
\-\ vasculitis\\:\\ 0\\.19805322614081902\ \(0\)\
\-\ hypointense\\:\\ 0\\.18780233420514536\ \(0\)\
\-\ accident\\:\\ 0\\.18234576089001361\ \(0\)\
\-\ glioma\\:\\ 0\\.18129183920817546\ \(0\)\
\-\ ring\\:\\ 0\\.17976461713512326\ \(0\)\
\-\ sequences\\:\\ 0\\.17072451274539183\ \(0\)\
\-\ hyperintense\\:\\ 0\\.1697577471788712\ \(0\)\
\-\ removal\\:\\ 0\\.16312814432714126\ \(0\)\
\-\ minimal\\:\\ 0\\.16280974457057673\ \(0\)\
\-\ astrocytoma\\:\\ 0\\.1611053952007704\ \(0\)\
\-\ effect\\:\\ 0\\.1497044577266241\ \(0\)\
\-\ followed\\:\\ 0\\.1441133168026053\ \(0\)\
\-\ radiation\\:\\ 0\\.14142333414578556\ \(0\)\
\-\ frontal\\:\\ 0\\.1373565202120367\ \(0\)\
\-\ abscess\\:\\ 0\\.13703675975622023\ \(0\)\
\-\ enhancing\\:\\ 0\\.13368876129148954\ \(0\)\
\-\ t1\\:\\ 0\\.13296789610715415\ \(0\)\
\-\ primary\\:\\ 0\\.13122425596491843\ \(0\)\
\-\ on\\:\\ 0\\.12890709258699837\ \(0\)\
\-\ following\\:\\ 0\\.12802583932284237\ \(0\)\
\-\ edema\\:\\ 0\\.12728253515897026\ \(0\)\
\-\ trauma\\:\\ 0\\.1239405031943527\ \(0\)\
\-\ lobe\\:\\ 0\\.12332855021733455\ \(0\)\
\-\ t2\\:\\ 0\\.1227807842741043\ \(0\)\
\-\ therapy\\:\\ 0\\.12261800629904913\ \(0\)\
\-\ metastatic\\:\\ 0\\.11704482404900954\ \(0\)\
\-\ man\\:\\ 0\\.112982014455032\ \(0\)\
\-\ had\\:\\ 0\\.10632881271492155\ \(0\)\
\-\ surgical\\:\\ 0\\.10372432309619728\ \(0\)\
\-\ lesion\\:\\ 0\\.10231360171582915\ \(0\)\
\-\ by\\:\\ 0\\.09062635204516566\ \(0\)\
\-\ disease\\:\\ 0\\.08958202434865505\ \(0\)\
\-\ and\\:\\ 0\\.08819721390207544\ \(0\)\
\-\ normal\\:\\ 0\\.08713395742545868\ \(0\)\
\-\ an\\:\\ 0\\.0816073476212724\ \(0\)\
\-\ mass\\:\\ 0\\.08151700286454512\ \(0\)\
\-\ ct\\:\\ 0\\.08124727029323787\ \(0\)\
\-\ left\\:\\ 0\\.07279887682152704\ \(0\)\
\-\ year\\:\\ 0\\.06576882477471638\ \(0\)\
\-\ old\\:\\ 0\\.06316083822740866\ \(0\)\
